ArticleBMC cancer2020

Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study.

Yusuke Kitagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.